MDCXW
Medicus Pharma Ltd. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-0.91
52W High
$2.50
52W Low
$0.31
50-Day MA
$2.50
200-Day MA
$2.50
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd. (MDCXW) is an innovative pharmaceutical company focused on developing and commercializing cutting-edge therapies to tackle significant healthcare challenges. With a strong pipeline backed by advanced research and technological expertise, Medicus Pharma aims to improve patient outcomes while maintaining strict adherence to regulatory standards. Its strategic positioning within the pharmaceutical sector underscores a commitment to pioneering healthcare solutions that not only meet evolving medical demands but also create substantial long-term value for investors.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -2865.00% |
| Return on Assets | -278.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.03 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $50.14M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/25/2026